Dr Frank Kern, MD in Brigantine, NJ - Dermatology

Dr Frank Kern, MD is a Dermatology - Procedural Dermatology physician based in Brigantine, New Jersey. Dr Frank Kern is licensed to practice in New Jersey (license number 25MA05012800) and his current practice location is 2201 Bayshore Ave, Brigantine, New Jersey. He can be reached at his office (for appointments etc.) via phone at (609) 266-4777.

NPI number for Dr Frank Kern is 1528155900 and his current mailing address is 2201 Bayshore Ave, Brigantine, New Jersey. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1528155900.

Contact Information

	Dr Frank Kern, MD
	2201 Bayshore Ave, Brigantine, NJ 08203-1927
	(609) 266-4777
	(609) 266-1673

Physician's Profile

Full Name	Dr Frank Kern
Gender	Male
Speciality	Dermatology - Procedural Dermatology
Location	2201 Bayshore Ave, Brigantine, New Jersey
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1528155900
Provider Enumeration Date: 10/06/2006
Last Update Date: 05/02/2008

Medical Identifiers

Medical identifiers for Dr Frank Kern such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1528155900	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207NS0135X	Dermatology - Procedural Dermatology	25MA05012800 (New Jersey)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Frank Kern is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Frank Kern, MD 2201 Bayshore Ave, Brigantine, NJ 08203-1927 Ph: (609) 266-4777	Dr Frank Kern, MD 2201 Bayshore Ave, Brigantine, NJ 08203-1927 Ph: (609) 266-4777

News Archive

Spire Corporation awarded grant to develop nanophase calcium phosphate coatings

Spire Corporation has announced that it has been awarded an SBIR Phase I grant for $156,878 from the National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), to develop nanophase calcium phosphate coatings loaded with bone morphogenic proteins (BMPs).

Adocia, Lilly terminate collaboration agreement relating to fast-acting insulin analog

Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.

Finnish researchers come together to study airborne transmission of coronavirus

Aalto University, the Finnish Meteorological Institute, VTT Technical Research Centre of Finland and the University of Helsinki have brought together a multidisciplinary group of researchers to model how the extremely small droplets that leave the respiratory tract when coughing, sneezing or talking are transported in air currents.

Researchers find association between physical fitness and children's brain development

Researchers have found an association between physical fitness and the brain in 9- and 10-year-old children: Those who are more fit tend to have a bigger hippocampus and perform better on a test of memory than their less-fit peers.

Dr Frank Kern, MD - Dermatology in Brigantine, NJ